EndoChoice® to Present at Investor Conferences in February 2016

ALPHARETTA, Ga., Jan. 26, 2016 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE: GI) announced today that Mark Gilreath, Founder and Chief Executive Officer, and David Gill, Chief Financial Officer are scheduled to participate in three investor conferences in February 2016.

Audio webcasts of the Company's presentations will be available by visiting the investor relations section of EndoChoice's web site at www.endochoice.com. Replays of the presentations will be available for 90 days.

About EndoChoice:
Based near Atlanta, Georgia, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®). EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.

Company Contact:
David Gill, Chief Financial Officer
678-585-1040 
[email protected]   

Investor Contacts:
Nick Laudico or Zack Kubow
The Ruth Group
646-536-7030 / 7020
[email protected]
[email protected]

SOURCE EndoChoice

Related Links

http://www.endochoice.com